Republic of the Philippines
HOUSE OF REPRESENTATIVES
Quezon City

15" CONGRESS
First Regular Session

House BiLLNo._ 3019

Introduced by REP. SALVADOR H. ESCUDERO IIT

EXPLANATORY NOTE

‘This bill proposes to professionalize the practice of pharmacy by setting @ national
standard for the profession, likewise creating a professional regulatory board to ensure
excellent, globally competitive, and accountable practice of the same.

Pharmacy as a health profession links the health sciences with the chemical sciences
and is charged with ensuring the safe and effective use of pharmaceutical drugs. The scope
of the pharmacy practice involves traditional roles such as compounding and dispensing
medications, but also includes more modern services related to health care, including
clinical services, reviewing medications for safety and efficacy, and providing drug
information. Pharmacists, therefore, are and should be experts on drug therapy, and are the
primary health professionals who optimize the use of medication to provide patients with
positive health outcomes. Education and experience in the field should therefore be
underscored.

is bill seeks to address the competency needs of the profession and also curb both
unintentional or intentional harm that may be caused by an unregulated practice. This
proposed measure will fulfill this objective through the:

1, Definition of the scope of nature and regulations of the professional practi

pharmacy:

2. Creation of the Professional Regulatory Board of Pharmacy;

3. Setting up of criteria or qualifications for the licensure of practitioners; and

4. Imposition of penalties for violators of this Act.

e of

In view of the foregoing, the passage of this bill is earnestly sought.

REE Wa
Me,
SAL’ YOR HL. S;CUDERO LIL

Representative
1* District, Sorsogon


HOUSE OF REPRESENTATIVES
Quezon City

15™ CONGRESS
First Regular Session

3019

HOUSE BILL NO.

Introduced by REP. SALVADOR H. ESCUDERO Il

AN ACT
REGULATING THE PRACTICE OF PHARMACY IN THE PHILIPPINES,
REPEALING FOR THE PURPOSE REPUBLIC ACT NO. 5921, THE PHARMACY
LAW, AS AMENDED, AND FOR OTHER PURPOSES.

Be it enacted by the Senate and the House of Representatives of the Republic of the
Philippines in Congress assembled:

ARTICLE I
GENERAL PROVISIONS,

Section 1. ~ Title. - This Act shall be known as the “Philippine Pharmacy Act of
2010”.

Sec. 2. - Statement of Policy. ‘The state recognizes the vital role of pharmacists in
quality healthcare delivery through their services in providing safe, effective, and quality
drugs or medicines; drug information, patient medication counseling, and health promotion.
The pharmacists’ professional service shall, therefore, be promoted as a component of the
total healtheare system, which shall ensure the physical well-being of the Filipinos.

Hence, the state shall develop and nurture competent, productive, morally upright, and well-
rounded pharmacists whose standards of professional practice and service shall be excellent,
qualitative, world-class and internationally recognized, globally competitive through
regulatory measures, programs, and activities that foster their continuing professional
development.

Sec. 3. — Objectives. - This Act provides for, and shall govern:

(a) the standardization and regulation of pharmacy education,

(b) the examination for registration of graduates of schools and colleges of
pharmacy,

(©) the supervision, control, and regulation of the practice of pharmacy in the
Philippines

(a) the enhancement of professional competence through continuing professional
development, research, and other related activities and

(e) the integration of the pharmacy profession.


See. 4. — Definition of Terms. ~ For purposes of this Act, the term:

(a) Biologic Products are microorganisms, sera, toxins and similar products used for
the prevention or cure of human diseases.

(b) Brand Name means the proprietary or trade name given by the manufacturer to
distinguish its product from those of the competitors.

(©) Cipher means a method of secret writing that substitutes other letters or
characters for the letter intended or transpose the letter after arranging them in
blocks or squares.

(4) Code means a system of words or other symbols arbitrarily used to represent
words.

(e) Compounding is the preparation, mixing, assembling, packaging, or labeling of a
drug (i) as the result of a prescription or drug order by a physician, dentist,
optometrist, or veterinarian, based on the said practitioner-patient-pharmacist
relationship in the course of professional practice, or (ii) for the purpose of, or in

relation to, research, teaching, or chemical analysis and not for sale or

dispensing.

(f) Cosmetics are (i) products intended to be applied, poured, sprinkled, or sprayed
on, introduced into, or otherwise applied to the human body, or any part thereof
for cleansing, beautifying, promoting attractiveness or improving the
appearance, or (ii) ingredients or other substances intended for use as a
component of any such product.

(g) Counterfeit drug/medicine/pharmaceutical refers to medicinal products with the
correct ingredients but not in the amounts as provided, wrong ingredient,
without active ingredienv’s, with insufficient quantity of active ingredient, which
result in the reduction of the drug’s safety, efficacy, quality, strength or purity.
It is a drug that is deliberately and fraudulently mislabeled with respect to
identity and/or source or with fake packaging, and can apply to both branded
and generic products. It shall also refer to:

(i) the drug itself or the container or labeling thereof or any part of such drug,
container, or labeling bearing without authorization the trademark, trade
name or other identification mark or imprint or any likeness to that which is
owned or registered in the Bureau of Patent, Trademark and Technology
Transfer (BPTTT) in the name of another natural or juridical person;

(i) a drug product refilled in containers by unauthorized persons if the
legitimate labels or marks are used;

(iii) an imported drug product not registered with the Food and Drug
Administration (FDA), except drugs brought in the country for personal use
as confirmed and justified by accompanying medical records; and

(iv) a drug which contains no amount of a different active ingredient or less than
cighty percent (80%) of the active ingredient it purports to possess as
distinguished from an adulterated drug including reduction or loss or
efficacy due to expiration.


(h) Dangerous drugs include those listed in the Schedules annexed to the 1961
Single Convention on Narcotic Drugs as amended by the 197 Protocol, and in
the Schedules annexed to the 1971 Single Convention on Psychotropic
Substances as enumerated in the attached annex in Republic Act No. 9165,
which is an integral part of the Act.

(i) Devices refers to any instrument, apparatus, implement, machine, implant, in
vitro reagent or calibrator, software, material or other similar or related article:

(a) intended by the manufacturer to be used, along or in combination, for human
beings for one or more of the specific purpose(s) of:

(H diagnosis, prevention, monitoring, treatment, alleviation of diseases
of diseases,

Gi) diagnosis, monitoring, treatment, alleviation of or compensation for an
injury

(iii) investigation, replacement or modification or support of the anatomy of a
physiological process,

(iv) supporting or sustaining life,

(¥) control of conception,

(vi) disinfection of medical devices,

(vii) providing information for medical or diagnostic purposes by means of an in
vitro examination of specimen derived from the human body; and

(b) which does not achieve its primary intended action in or on the human body by
pharmacological, immunological or metabolic means, but which may be assisted in
their intended function by such means.

() Dispensing is a process whereby a pharmacist receives and checks a valid
prescriber’s medication order or prescription, and makes available drugs and
medicines, with advice an their proper use and other relevant information.

(k) Drugs and Medicines refer to chemical compounds or biological substances,
other than food, intended for use in the treatment, prevention or diagnosis of
disease in humans or animals, including but not limited to:

(i) any article recognized in the official United States Pharmacopocia,-National
Formulary, official Homeopathic Pharmacopoeia of the United States,
Philippine Pharmacopoeia, Philippine National Drug Formulary, British
Pharmacopoeia, European Pharmacopoeia, Japanese Pharmacopoeia, and
any official compendium or any supplement to them;

(ii) any article intended for use in diagnosis, cure, mitigation, treatment, or
prévention of disease of man and animals;

(ii) any article other than food intended to affect the structure or any function of
the human body or animals;


(iv) any article intended for use as a component of articles specified in clauses
@, Gi, and (iii) not including devices or their components, parts,
accessories; and

(v) herbal and/or traditional drugs which are articles of plant or animal origin
used in folk medicine which are: (a) recognized in the Philippine National
Drug Formulary; (b) intended for use in the treatment, or cure or mitigation
of disease symptoms, injury or body defects in humans; (c) other than food,
intended to affect the structure or any function of the human body; (d) in
finished or ready-to-use dosage form; and (e) intended for use as a
component of any of the articles specified in clauses (a), (b), (c) or (d).

() Drug or Pharmaceutical Laboratory or Pharmaceutical Manufacturing
Laboratory means an establishment where pharmaceutical products, proprietary
medicines, or pharmaceutical specialties are formulated, prepared, compounded,
and standardized.

(m) Drug Establishments means FDA-registered companies involved in the
‘manufacture, importation, repacking, and/or distribution of drugs or medicines.

(n) Drug Outlets refer to drugstores, pharmacies, and other business establishments
which are registered with the FDA and which legally sell drugs and medicin

(0) Drugstore or Pharmacy means a place or establishment licensed by FDA where
drugs, chemicals, pharmaceutical products, specialties, and devices are legally
sold at retail or wholesale and where medical, dental, and veterinary
prescriptions are compounded and dispensed.

(p) Expiration Date means the date after which the product is not expected to
possess its claimed potency, efficacy, quality, and safety; and after which it is
not legal to sell or distribute or use the said product.

(@) Filling of a prescription refers to the act of dispensing or giving out of medicines
in accordance with the doctor’s order.

(®) Household Remedies shall refer to any preparation containing pharmaceutical
substances of common or ordinary use to relieve common physical ailments
which may be dispensed without a medical prescription in original packages,
bottles or containers, the nomenclature of which has been duly approved by
FDA in the process of registration as defined in FDA AO No.115 s. 1991)

(s) Generic Name means the scientifically and internationally recognized name of
the active ingredients as approved by the Food and Drug Administration.

() Label means a display of written, printed or graphic information upon the
immediate container, or attached to or accompanying any pharmaceutical
products.

(u) Labeling means all labels and other written, printed, or graphic matter (1) upon
any item or any of its containers or wrappers or (2) accompanying any-such
item. .

(v) Over-the- counter drugs are drugs used for symptomatic relief of minor ailments
which may be dispensed without a prescription.


(w) Pharmaceutical products or Pharmaceutical specialties are drugs, preparations,
or mixture of drugs under a brand or generic name and intended for the cure,
mitigation, treatment, or prevention of disease in man or animals.

(8) Pharmacist-only over-the-counter drugs are FDA-classified over-the-counter
drugs and/or substances which should only be obtained from the drugstore or
pharmacy with mandatory pharmacist’s advice on their selection and proper use.

(¥) Person includes an individual, partnership, corporation, or any juridical entity.

(2) Pharmaceutical marketing means any activity undertaken, organized ot
sponsored by a drug establishment which is directed at promoting the
prescription, recommendation, supply, administration or consumption of its
pharmaceutical product(s) through direct personal contact and all media,
including the internet,

(aa) Pharmacy Assistants are those persons who assist pharmacists in dispensing
medicines in community, hospital, industrial settings and in other activities, such
as, but not limited to medical missions, under the supervision of the pharmacist
and as described in Sections 17 and 42 of this Act.

(bb) Physician's samples refer to medicines given to a physician for free for
promotional purposes.

(cc) Prescription drugs are those drugs which can only be dispensed by a pharmacist
to a patient upon the presentation of a valid prescription from a physician,
dentist, optometrist or veterinarian and for which pharmacist’s advice on their
proper use is necessary.

(dd) Refilling of a prescription refers to the act of dispensing or giving out the
remaining balance of medicines ordered in the prescription when the whole
quantity ordered is not yet completely filled.

(ce) Secret Keys means a characteristic style or symbols kept from the knowledge of
others or disclosed confidentially to a few individuals.

Sec. 5.— Enforcement. - The Professional Regulatory Board of Pharmacy and the
Professional Regulation Commission are the body responsible for the implementation of the
provisions of this Act.

ARTICLE II
THE PROFESSIONAL REGULATORY BOARD OF PHARMACY

See. 6. - The Board of Pharmacy and its Composition. ~ There is hereby created a
Professional Regulatory Board of Pharmacy, hereinafter called the Board, under the
administration, control, and supervision of the Professional Regulation Commission therein
after called the Commission, composed of a Chairman and four (4) members, each of which
represent the areas of practice of community, hospital, manufacturing, academe, and
government service, who shall be appointed by the President of the Philippines from the
recommendees ranked by the Commission from the list of nominees submitted by the
Accredited Integrated National Organization for Pharmacists.

Sec. 7. - Qualifications of Board Members. ~ To be appointed as member of the
Board of Pharmacy, a person shall be:


(a) Accitizen of the Philippines and a resident for at least five (5) years;

(b)__ A duly registered pharmacist, preferably a holder of a Master of Science in
Pharmacy, or its equivalent degree and has been in the practice of pharmacy for at
least ten years;

(©) Of good moral character with a valid certificate of registration, valid
professional identification card and preferably with teaching experience; and
preferably representing each field of practice;

(d) At the time of appointment, not a member of the faculty or administrative office
of any school, college or university offering degree programs in pharmacy nor
connected in a review school or center; nor has any direct or indirect pecuniary
interests in any school, college, or any institution offering pharmacy; and

(©) A member of good standing for at least five (5) years of the accredited integrated
national pharmacy association but, at the time of nomination, not an officer or
trustee thereof.

Sec. 8. Term of Office of Board Members. - The chairman and the members of the
Board shall hold office for three (3) years after appointment or until their successors shall
have been appointed and duly qualified; Provided, the incumbent Board members shall
finish their terms to complete the membership of the Board. Provided, further, that the
chairman or any member may be re-appointed for another term but in no case shall he/she
serve for more than six years.

Sec. 9. — Compensation of the Board of Pharmacy. - As provided for in R.A. No.
8981, known as the “PRC Modemization Act of 2000”, the members of the Board shall
receive allowances and benefits equivalent to at least two salary grades lower than the
salary grade of the Commissioner, while the chairman of the Board shall receive a monthly
compensation equivalent to two steps higher than the members of the Board. The chairman
and members shall be entitled to other allowances and benefits provided under existing
laws.

Sec. 10. - Powers, Functions and Duties of the Board. ~ The Board shall exercise

these specific powers, functions, and duties:

(a) Conduct licensure examination for pharmacists;

(b) Approve the registration of pharmacists and the certification of drug handlers as
covered by Sec. 42 of this Act;

(c) Prepare, adopt, and issue the Table of Specifications for the subjects in the board
licensure examination for pharmacists in consultation with the academe; determine
and prepare the questions therefor; score and rate the examination papers with the
name and signature of the Board member concerned appearing thereon and submit
the results in all subjects duly signed by the members of the Board to the
Commission no later than three (3) days from the last day of examination unless
extended by the Commission for justifiable cause/s;

(d) Review and/or amend the scope of licensure examination;

(e) Add, delete, modify the scope, definition and standards of practice of pharmacy;


(®) Reprimand any pharmacist, suspend, or revoke his/her certificate of registration on
the grounds as provided for in Sec. 46 hereof, after a formal administrative
investigation;

(g) Promulgate from time to time the necessary rules and regulations for the effective
enforcement of this Act;

(h) Monitor the conditions affecting the practice of pharmacy in the Philippines and
adopt measures that may be deemed proper for the enhancement of the profession
and/or the maintenance of high professional, academic, ethical and technical
standards;

(® Verify or confirm the qualifications and conditions of pharmacists employed in
drugstores, hospital pharmacies, drug or pharmaceutical laboratories, drug traders,
importers, cosmetics and medical device establishments for which the Board may
designate inspectors from the Food and Drug Administration and other related
institutions for such purpose;

(@ Investigate cases arising from violations of this Act, the rules and regulations
promulgated thereunder and the Pharmacist’s Code of Ethics, technical standards,
and other Board issuances and for this purpose, may issue summons, subpoena
duces ad testificandum and subpoena duces fecum to the respondents and/or
witnesses to compel their attendance in such investigations or hearings: Provided
that, the decision of the Board shall, unless appealed to the Commission, becomes
final and executory after fifteen (15) days from receipt of notice of judgment or
decision;

(kK) C
in accordance with the Revised Rule of

ite a person in contempt for failure or refusal to obey the lawful order of the Board
Sourt;

(1) Delegate the hearing or investigation of administrative cases filed before them
whereat the hearing shall be presided over by at least one (1) member of the Board
concemed assisted by a Legal or Hearing Officer of the Commission, provided that
if the charge is not related to the technical practice of the profession, the hearing
may be conducted without a member of the Board;

(m)Conduct, through the Legal Officers of the Commission, summary proceedings on
minor violations of the respective regulatory laws, as determined by the Board.
Violations of the rules and regulations issued by the Board to implement this Act,
including violations of the general instructions to examinees committed by
examinees, and render summary judgment thereon which shall, unless appealed to
the Commission, become final and executory after fifteen (15) days from receipt
of notice of judgment or decision;

(n) Subject to the final approval by the Commission, recommend registration without
examination and the issuance of corresponding certificate of registration and
professional identification card to foreign pharmacists duly licensed in countries
with agreement of reciprocity with the Philippine government;

(0) Prepare an annual report of accomplishments on programs, projects, and activities of
the Board during the year for submission to the Commission after the close of each
calendar year including appropriate recommendations on issues or problems
affecting the practice of pharmacy;



(p) Issue and promulgate guidelines on continuing professional development education
in coordination with the accredited professional organization;

(q) Recommend to the CHED for the closure of the program or course of pharmacy
offered by a school/college pursuant to the latter's policy thereon; and

(®) Perform any implied, incidental, necessary power for the effective implementation
of this Act.

Sec. 11. - Grounds for Suspension or Termination of Term of Office of the
Chairman or Member of the Board from his/her Office. - Vhe President of the Philippines,
upon the recommendation of the Commission, after giving the Chairman or the member of
the Board an opportunity to defend himself/herself in an administrative investigation
conducted by the Commission, may remove or suspend him/her on any of the following
grounds:

(a) Gross neglect, incompetence or dishonesty in the discharge of his/her duty;

(b) Violation of any of the causes/grounds/ and the prohibited acts provided in this
Act and the offenses in the Revised Penal Code, the Anti-Graft and Corruption
Practices and other laws;

(c) Involvement in the manipulation, tampering or rigging of the licensure
examination, its questions and/or its results and the disclosure of classified and
confidential information pertaining to the licensure examination.

(4) Conviction of an offense involving moral turpitude by a court of jurisdiction,

The Commission, in the conduct of investigation shall be guided by Section 7, and
Section 15 of R.A. No. 8981 and the rules on administrative investigation thereof, and
the applicable’ provisions of the New Rules of Court.

ARTICLE Il

EXAMINATION, REGISTRATION, CERTIFICATION, AND LICENSURE

Sec. 12. - Passing of Licensure Examination Requirement. — Except as otherwise
specifically allowed under this Act, applicants for registration for the practice of pharmacy
shall be required to pass a licensure examination as provided for in this Act and in
accordance with Sec. 7 (d) of R.A. No. 8981.

See. 13. - Qualifications of Applicants. — An applicant for the licensure
examination for pharmacy shall satisfactorily show that he/she possesses the following
qualifications:

(a) Citizen of the Philippines or a foreign citizen whose country/state has reciprocity
with the Philippines in the practice of pharmacy;

(b) Of good moral character and reputation;

(©) A holder of a Bachelor’s degree in pharmacy duly recognized or accredited by the
Commission on Higher Education (CHED) and conferred by a school/
college/university duly authorized by the government or its equivalent degree
obtained by either a Filipino or foreign citizen from an institution of learning in a
foreign country/state, provided it is duly recognized and/or accredited by CHED:

9


(@) Not convicted of an offense involving moral turpitude by a court of competent
jurisdiction; and

(©) He must have completed an Internship Program which shall consist of at least nine
hundred sixty hours (960 hours), six hundred hours (600 hours) of which shall be
spent equally distributed in a community pharmacy, hospital pharmacy, or
pharmaceutical industry — manufacturing, regulatory, marketing, or research — and
other related fields, while three hundred sixty hours (360 hours) of internship shall
be spent in any of the accredited pharmacy establishments or entity chosen by the
candidate.

For this purpose, the abovementioned community pharmacy, pharmaceutical company,
and hospital pharmacy shall keep a separate record of pharmacy students who
underwent said internship program directly under their contro! and as a result thereof,
shall issue the proper certificate of said hours of internship. It shall also be the duty of
said establishments to submit semi-annually a complete report of the names of those
who have undergone training under their supervision and the corresponding number of
hours of internship credit of each of the pharmacy students to their respective colleges
or schools and to the Board.

See. 14. - Scope of Examination. ~ The licensure examination for pharmacists shall
be divided into two major divisions: Pharmacy as Science and Pharmacy as Practice.
Pharmacy as Science shall consist of subjects in Group I (Public Health, Pharmaceutical
Microbiology and Parasitology), Group Il (Drug Delivery Systems, Physical Pharmacy,
Manufacturing Pharmacy, Quality Control I, Quality Control I1), Group III (Pharmaceutical
Biochemistry, Pharmacognosy, Plant Chemistry, and Philippine Medicinal Plants,
Pharmacy and Chemistry of Medicinals | and Pharmacy and Chemistry of Medicinals II,

Pharmacy as Practice shall be made up of the following subjects: Group IV (Pharmaceutical
Calculations, Hospital Pharmacy, Clinical Pharmacy, Dispensing and Medication
Counseling), Group V (Biopharmaceutics and Pharmacokinetics, Pharmacology |,
Pharmacology HU, Clinical Toxicology), and Group VI (Pharmaceutical Jurisprudence and
Ethics, Pharmaceutical Marketing and Entrepreneurship and Pharmaceutical Administration
and Management).

‘The subjects shall be weighed as follows: Group I, 10
Group IV, 20%; Group V, 20%; and Group VI, 10%.

»; Group II, 20%; Group III, 20%;

The Board subject to the approval by the Commission may introduce relevant changes, as
the need arises, to the content of the examination and the relative weight attributed to each
subject in the examination may be made after ‘consultation with the duly recognized
association of schools or colleges of pharmacy and the CHED.

Sec. 15. — Holding of Examination. ~ Examination for registration to practice
pharmacy in the Philippines shall be given twice a year in such places and dates as the
Commission may designate in the Resolution thereof on the Master Schedules for all
licensure examinations in accordance with Sec. 7 (d) of R.A. No. 8981. The said places and
dates may be subject to change under valid circumstances and reasons.

Sec. 16. — Ratings in the Licensure Examination. ~ In order to be registered and
licensed as a pharmacist, a candidate must obtain a general weighted average of seventy-
five per cent (75%) or over with no ratings of fifty percent (50%) in more than two (2)
subjects.

10


Sec. 17. Registration and Licensure of Pharmacy Assistant. ~ A general weighted
average below 75% but not lower than 70%, with no ratings of fifty percent (50%) in more
than two subjects, shall qualify an examinee to _be registered and licensed by the
Professional Regulation Commission to practice as @ pharmacy assistant who shall work
under the supervision of a registered pharmacist, To be licensed as a pharmacist, a
pharmacy assistant must pass succeeding board licensure examination for pharmacists with
a general average rating as provided in Section 16.

See. 18. — Report of Rating. The Board shall submit to the Commission the ratings
obtained by each candidate within ten (10) calendar days after the examination, unless
extended for just cause. Upon the release of the results of the examination, the Commission
shall send by mail the rating received by each examinee at his/her given address using the
mailing envelope submitted during the examination.

Sec. 19. — Oath of Profession. — All successful candidates in the licensure
examination shall take their oath of profession before the Chairman or any member of the
Board or any authorized officer of the Commission to administer oaths, prior to entering the
practice of pharmacy.

See. 20. ~ Issuance of Certificate of Registration and Professional Identification
Card, ~ A certificate of registration shall be issued to those who are registered upon
payment of fees prescribed by the Commission. It shall bear the signatures of the
Chairperson and the Commissioners of the Commission and the Chairman and Members of
the Board, stamped with the official seal of the Commission and of the Board, certifying the
person named therein is entitled to the practice of the profession with all the privileges
appurtenant thereto. Until revoked or suspended in accordance with this Act, it shall remain
in full force and effect.

A professional identification card bearing the registration number and date, its
validity and expiry duly signed by the Chairperson of the Commission shall likewise be
issued to every registrant who has paid the prescribed fee. It shall be reissued upon
compliance with the continuing professional development education requirement as
specified in Article IV, Sec. 27 (d) of this Act and upon payment of the prescribed three-
year registration fees therefor.

Sec. 21.—Affixing RPh after a Registered Pharmacist’s Name. — Only phermacists
who are duly registered and licensed by the Board and the Commission has the right to affix
this title, “Registered Pharmacist” or “R.Ph.” after his/her name.

See. 22. - Grounds for Non-registration. — The Board shall not register any
successfiul examinee for registration who has been:

(a) Convicted of an offense involving moral turpitude by a court of competent
jurisdiction,

(b) Found guilty of immoral or dishonorable conduct by the Board,

(©) Summarily adjudged guilty for violation of the General Instructions to Examines
by the Board,

(@) Declared of unsound mind by the court of competent jurisdiction, and

(e) Found addicted to dangerous drugs.


In refusing such registration, the Board shall give the applicant a written statement setting,
forth the reasons therefor and shall file a copy in its records,

Sec. 23. - Reissuance of Revoked Certificate of Registration, Replacement of Lost
or Damaged Certificate of Registration, Professional Identification Card or
Temporary/Special Permit. ~The Board may upon petition, reinstate or reissue a revoked
certificate of registration after two (2) years from the date of the revocation of the certificate
of registration or the surrender of the revoked certificate and/or the professional
identification card if still valid, to the Board and/or the Commission. The Board may or may
not require the pharmacist whose certificate had been revoked to take another licensure
examination. The petitioner shall prove to the Board that he/she has valid reason/s to be
reinstated to the practice of pharmacy. For the grant of his/her petition, the Board shall issue
a Board Resolution subject to the approval of the Commission.

Duplicate copy of lost or damaged certificate of registration, professional identification card
or temporary/special permit may be reissued in accordance with rules thereon and upon
payment of the prescribed fee therefor.

See. 24. —_Non-payment of the PRC Registration Fees. - ‘The Board shall suspend a
registered pharmacist from the practice of his/her profession for non-payment of the PRC
-tegistration fees for more than three (3) consecutive years from its last or previous year of
payment. The resumption of his/her practice shall take place only upon payment of
delinquency fees plus surcharges and interest and in accordance With the rules of the
Commission. The running of the three-year period may be interrupted upon written notice
about the discontinuance of his/her practice and surrender of his/her certificate of
registration with professional identification card to the Board and/or the Commission.

See. Vested Rights: Automatic Registration. — All pharmacists registered
before the effectivity of this Act shall automatically be registered hereunder, subject to the
policy as to future requirements.

Certificates of registration and professional identification cards or temporary/special
permits held by such persons in good standing at such effectivity shall have the same force
and effect as though they were issued on or after the said effectivity.

ARTICLE IV
REGULATION OF THE PRACTICE OF PHARMACY

See. 26. - Scope of the Practice of Pharmacy. ~ A person deemed to be practicing
pharmacy within the meaning of this Article is one who shall, with or without a fee, salary,
percentage or other rewards, paid or given directly to himself or indirectly through another —

(a) Prepare, compound or manufacture, analyze, assay, preserve, store, distribute, sell
and/or dispense any medicine, drug, chemicals, cosmetics, pharmaceuticals, devices
or contrivances used in pursuance thereof; or

(b) render services, such as but not limited to (i) regulatory services, (ii)
pharmaceutical marketing, (iii) drug information service and (iv) medication
management which covers the following: drug selection and procurement, storage
and distribution, dispensing, medication counseling and medication therapy
monitoring, whenever the expertise and the technical knowledge of the pharmacist

is required, in any drug establishmenvoutlet or healthcare institution or

(©) provide other services where pharmaceutical knowledge is req}

ed; or


(d) engage in teaching scientific, technical or professional pharmacy courses in a
school or college of pharmacy; or

(©) conduct or undertake scientific research in all aspects involving drugs and
healthcare, or

(O) dispense drugs during medical missions and in other situations where supervision of
drugs is required.

All government and non-government agencies, establishments, institutions, and
regulatory body with functions that involve the practice of pharmacy shall be headed and
managed only by a qualified, duly registered and licensed pharmacist.

All pharmacists are expected to abide by current standards such as the Good
Pharmacy Practice, Good Laboratory Practice, Good Distribution Practice, Good
Manufacturing Practice, and Good Clinical Practice, which are deemed vital in the
performance of one’s roles and functions in different practice areas.

‘The Board, subject to the approval by the Commission, may add to, delete, or
modify the above acts, services, or activities as the need arises.

Sec. 27. ~ Prerequisites for the Practice of Pharmacy. — A person can practice
pharmacy in the Philippines provided he/she:

(a) has satisfactorily passed the licensure examination for pharmacists given by the
Board and the Commission,

(b) is duly registered with and livensed by the Board and the Commission,
(©) is an active member of the accredited integrated national professional organization,
(d) has submitted continuing professional development education units as required by

the Continuing Professional Education Council for pharmacists or pertinent laws and
regulations for the renewal of his/her professional identification card, and/or

(©) a holder of a valid temporary/special permit issued by the Board and the
Commission to foreign licensed pharmacists pursuant to this Act,

See. 28. — Foreign Reciprocity. — No foreigner shall be allowed to take the licensure
examination for pharmacists, register, receive his/her certificate of registration and
professional identification card, and practice pharmacy in the Philippines unless. the
Fequirements for the licensure examination and registration and practice of pharmacy
imposed under the laws and the regulations in his/her foreign country or state are
substantially the same as those required and contemplated by the Philippine laws and
regulations, and unless the said foreign laws and regulations allow Filipino citizens to
practice pharmacy within the territory of the said foreign country/state on the same basis
and grant the same privileges as those enjoyed by the citizens, subjects or nationals thereof.

Sec. 29. — Practice through Temporary/Special Permit. ~ A temporary/ special
permit may be issued by the Board subject to the approval of the Commission and payment
of applicable fees to the following:

(@) licensed pharmacists from foreign countries whose services whether for free or a fee

13


(1) if they are internationally renowned pharmacists or experts in any field or
specialty of pharmacy,

(2) if their services are deemed necessary for lack of specialists or experts in a
particular field,

(b) licensed pharmacists from foreign countries or states whose services shall be for free
and limited to indigent patients as beneficiaries; or

(©) licensed pharmacists from foreign countries or states employed as visiting faculty in
a field or specialty of pharmacy.

‘The permit shall, among other things, contain these limitations and conditions for a
period of no more than one year, subject to renewal, the field or specialty of pharmacy, and
the specific place of practice including clinics, hospitals, and schools of pharmacy. The
Board subject to the approval by the Commission shall promulgate rules and regulations on
the implementation of this particular Section.

See. 30. — Indication of Numbers: Certificate of Registration, Professional Tax
Receipt and Accredited Integrated National Organization (AINO) Membership. - The
Pharmacist shall be required to indicate on any document he/she signs, uses or issues in
connection with the practice of pharmacy the following information:

(a) his/her registration number and date of issuan
(b) the expiration date of his/her professional identification card,
(c) the Professional Tax Receipt (PTR) Number and date of issuance, and

(d) the certificate of AINO membership (annuaV/lifetime), number and the official
receipt of payment, number and date.

Sec. 31. — Registry of Pharmacists. — The Board shall prepare and maintain a
registry of the names, residences and/or office addresses of all registered pharmacists which
shall be updated annually in cooperation with the Accredited Integrated National
Organization (AINO), ting therein the status of the certificate of registration,
professional identification card and Accredited Integrated National Organization (AINO)
membership, whether valid or inactive due to death, or other reasons, delinquent, suspended
or with revoked certificate of registration. The said registry of pharmacists shall be
conspicuously posted within the premises of the Commission and the information therein
made available to the public upon inquiry or request.

See. 32. — Display of Certificate of Registration. — \t shall be the duty of every
pharmacist engaged in the practice of pharmacy either on his/her own account or under the
employ of another to display his/her original certificate of registration in a prominent and
conspicuous place in a retail drug outlet or drug establishment which he operates or in
swhich he/she is employed in his/her professional capacity as pharmacist. No pharmacist
shall, with his/her knowledge, allow his/her certificate of registration to be displayed in such
establishment when he/she is not actually employed or operating therein in his/her
professional capacity.

See. 33. - Compounding and Dispensing. — No drug or pharmaceutical product of
whatever nature and kind shall be compounded, dispensed, sold or resold, or otherwise be
made available to the consuming public except through a FDA-licensed retail drug outlet or

14


other business establishments which are duly established in accordance with the provisions
of applicable laws.

Prescription drugs and pharmacist-only over-the-counter drugs shall be dispensed
only by registered pharmacists.

Prescription drugs shalll be dispensed only upon presentation of a valid prescription.

Compounding and dispensing by duly registered and licensed pharmacists shall be in
accordance with current good manufacturing practice, good laboratory practice, and good
pharmacy practice, with the safety and protection of individual patients as. ultimate
objective.

Licensed pharmaceutical manufacturers, importers and wholesalers are authorized to
sell their products only to duly licensed drug outlets, wholesalers and other drug
establishments.

A registered and licensed pharmacist may refuse to compound, dispense or sell
drugs and pharmaceutical products, if not in accordance with this Act.

Sec. 34. — Pharmacist Requirement and Compensation. ~ very drug
establishment/outlet selling prescription and pharmacist only over-the-counter drugs
whether owned by the government or a private person or firm shall at all times when open
for business be under the direct control, supervision, and responsibility of a registered and
licensed pharmacist. For retails outlets selling only over-the-counter drugs, they shall be
under the supervision of a registered and licensed pharmacist.

Processes involving the preparation, quality control, or repacking of pharmaceutical
products in quantities greatly in excess of single therapeutic doses shall for each respective
operation be under the direct and immediate supervision of a registered and licensed
pharmacist. In the sale of pharmaceutical products, medicines and drugs, at wholesale, such
business shall be conducted under the immediate supervision of a registered and licensed
pharmacist.

All government and non-government agencies and units which handle the
procurement and distribution of drugs should have a supervising pharmacist. All rural health
units dispensing medicines should be supervised by a pharmacist or a pharmacy assistant as,
defined in this Act.

Pharmacists in government service shall receive a starting salary equivalent to
Salary Grade 15 as provided in R.A. 6758 (Compensation and Position Classification Act of
1989) and its amendments. Those pharmacists in the private sector shall receive an entry-
level salary in peso equivalent of Salary Grade 15 being received by government
pharmacists.

Sec. 35. — Responsibility for Quality of Drugs, Cosmetics and Medical Devices. ~ It
shall be the duty of the registered pharmacist of drug outletestablishment to ensure that all
drug products, cosmetics and medical devices conform to standards of safety, quality and
efficacy and strictly adhere to the guidelines as provided for in this Act and other pertinent
rules and regulations and issuances. Owners, managers, and/or pharmacists in charge of the
operation of drug outlets and drug establishments shall be held responsible.

It shall be unlawful for any, person to manufacture, prepare, sell or dispense any
prescription drug, pharmaceutical, medical devices, or cosmetics under any fraudulent
name, direction o pretense or to adulterate any drug, pharmaceutical, medical devices, or

15


cosmetics offered for sale. Any drug, pharmaceutical product, medical device/s or cosmetics
shall be held to be adulterated or deteriorated within the meaning of this section if it differs
from the standard or quality or purity given in the United States Pharmacopeia/National
Formulary and Philippine Pharmacopeia, in its latest edition, or any standard reference for
drugs and medicines given official recognition, and those which fall within the meaning as
provided for in the Food Drug, Cosmetic and Devices Act, R.A. No. 3720, as amended by
pertinent laws and the Food and Drug Administration Act, R.A. 0711.

In cases of drug products sold in their original packings, the seal of which has not
been broken or tampered with, the liability that may arise because of their quality and
purity, rests upon the manufacturer or importer, the distributor, representative, or dealer
who is responsible for their distribution or sale,

See. 36. - Filling and Partial Filling of Prescription.- All. prescriptions shall
be filled or compounded only by a registered and licensed pharmacist following the
standards of purity, safety and quality. Completely filled prescriptions should be
surrendered to the pharmacist for recording.

Partial filling of prescription is dispensing units less than the total quantity indicated
in the prescription. The prescription should contain information as to how many units were
served and shall be retumed to the buyer after being recorded in the appropriate book or
equivalent system. The drugstore, which completes the filling of the prescription, shall keep
the prescription on file for a prescribed period of time.

See. 37. - Physician’s sample. — Drugs, biologic products, devices or proprietary
medicines, given or intended to be given free to the physician and other qualified person by
any manufacturer or distributor or its medical representative/detailman as part of its
program or promotion, should not be sold.

The statement “Sample, not for sale” shall appear conspicuously on the container, package,
* or carton of the drug or device to be given. It shall be unlawful to remove, erase, deface
already marked original labels of samples.

See. 38. — Prohibition against use of cipher or unusual terms in prescriptions and
prescription switching ~ Pharmacists should not compound or dispense prescriptions,
recipes or formulas which are written in ciphers, codes or secret keys or prescriptions of
g unusual names which differ from those in standard pharmacopeias or
formularies.

The pharmacist dispensing or compounding prescriptions should not substitute the
drug or drugs called for in the prescription with any other drug or substance or ingredient
without prior consultation with, and a written consent of the person prescribing, except in
accordance with RA 6675, known as the Generics Act of 1988, and other pertinent laws and
regulations.

Sec. 39, - Label of Dispensed Medicines. - Upon every box, bottle or package
containing medicine compounded or dispensed by a registered and licensed pharmacist
based on prescription, there shall be pasted, affixed or imprinted a seal or label bearing,
among others, name of patient, generic name of drug; brand name, if any, strength, expiry
date, directions for use, and name and address of drugstore and other requirements
prescribed by the Cheaper Medicines Act (RA 9502) and its implementing rules and
regulations.

16


Every prescription which in its preparation contains any quantity of a drug, which is

“habit-forming, or a derivative of such drug, shall have an auxiliary label or a notation,
“Warning — May be habit forming”. Such prescriptions should comply with the
requirements of the R. A. 9165, the Comprehensive Dangerous Drugs Act of 2002, and any
future amendments thereto.

Filled prescription for external use shall bear the auxiliary label, “For External Usé

Sec. 40. - Record Books for Prescription. ~ All prescriptions dispensed in the
drugstore shall be recorded in the book or an equivalent recording system approved by FDA
for this purpose indicating therein, among others, the prescription number, name of
prescriber, generic name and brand, dosage strength, quantity of drug, name of the patient
and address, and initials of pharmacist. It shall be open to inspection by the proper
authorities at any time of the day when the pharmacy is open to the public and must be
preserved for a period of not less than two (2) years after the last entry in it has been made.

All prescriptions shall be attached to the prescription book or compiled (for equivalent
recording system) and numbered consecutively and shall be preserved for the same period
of time as required.

All required information on dangerous drugs dispensed by a pharmacy shall be recorded in
the Dangerous Drugs book or an equivalent recording system as required by R.A. 9165.

Sec. 41. — Requirements for the Opening and Operation of Retail Drug Outlet or
Establishment, - The minimum requirements necessary for the opening of retail drug outlet
or establishment shall be in accordance with the rules and regulations prescribed by the
Food and Drug Administration in accordance with the provisions of this Act.

The application for the opening of a retail drug outlet or other business establishments
should not be approved unless applied for by a Filipino registered pharmacist cither as
owner or as pharmacist-in-charge pursuant to the provisions of this Act.

Sec. 42. - Handling of Drugs by Persons Other than a Pharmacist. ~ For the
purpose of this section, persons handling drugs other than the pharmacist are: professional
‘medical representatives, pharmacy assistants, pharmacy aides/clerks, and other persons who
assist pharmacists. in dispensing medicines or any other person performing functions
involving the handling of drugs and drug products. It is preferred that these positions are
occupied by those who finished pharmacy degree, not necessarily licensed as pharmacists
and who has undergone the prescribed training from a Commission-accredited provider.

The professional medical representative or detailman is one who represents any duly
authorized manufacturer, distributor, trader and wholesaler of drugs, pharmaceuticals,
biologic products and devices, whose primary duty is to introduce said products to
“legitimate prescribers and which forms part of their program for promotion by describing its
use, composition, action, dosage, administration, contraindication, advantages and other
relevant information about the drugs being promoted.

‘The pharmacy assistant is one who helps the pharmacist in compounding, dispensing
of medicines and, giving of information on proper use of medicines while the pharmacy
aide/clerk is involved in other aspects of operation assigned by the pharmacist.

Any person who shall be employed or engaged as professional medical
representative or pharmacy aide/clerk shall undergo comprehensive standardized training
programs approved by the Board with providers approved and/or accredited by the Board in
accordance with criteria established therefor.

17


ARTICLE V

ACCREDITED INTEGRATED NATIONAL ORGANIZATION FOR PHARMACISTS

Sec. 43. — The Accredited Integrated National Professional Organization (AINO)
of Pharmacists ~ The pharmacists are integrated under one national accredited professional

organization that is duly registered with the Securities and Exchange Commission
‘The Board subject to the approval by the Commis

2C).
ion shall accredit the said organization as

the only integrated national organization for registered pharmacists (and pharmacy
assistants). All pharmacists (and pharmacy assistants) whose names appear in the registry
shall ipso facto or automatically become members thereof and shall receive all the benefits
and privileges accorded to its members upon payment of the required fees and dues,
Membership to the foregoing shall not be a bar to membership in any other association of

pharmacists.

Sec. 44. — Membership to the Accredited Integrated National Professional
Organization. — All registered pharmacists (and pharmacy assistants) must be members of
the AINO and must maintain membership throughout the duration of the practice of the
profession. Professional identification card shall not be renewed if the requirements for
membership with AINO are not met including credit units for attendance to duly accredited
continuing professional development (CPD) education activities.

See. 45.

pecialty Boards in Various Areas of Pharmacy Practice. — Specialty

Boards created within the affiliate organizations and societies for recognition of the AINO
(1) for the Board, subject to the approval of the Commissioner shall accredit specialties in
various areas of practice, (2) setting standards of practice within different specialties, and
(3) establishing qualifications and requirements for certification of practitioners under each

specialty.

ARTICLE VI

VIOLATIONS, ADMINISTRATIVE SANCTIONS, AND PROCEDURES

See. 46. — Revocation or Suspension of the Certificate of Registration and
Cancellation of Temporary or Special Permit, - The Board shall have the power, upon
notice and hearing to revoke or suspend the certificate of registration of a registered
pharmacist or to cancel a temporary or special permit granted to a foreign pharmacist on the
basis of the following:

(a)

(b)

(©)

(d)

Violation of this Act on unauthorized practice of pharmacy, violation of any
provision of this Act, the Rules and Regulations (RR) thereof, the Code of
Ethics for Pharmacists, Code of Good Governance, Code of Technical
Standards for the practice of pharmacy, policy, and measure of the Board
and/or the Commission;

Malpractice or gross incompetence; negligence, or imprudence resulting to
death or injury of the patient;

n by a competent court of any
criminal offense involving moral turpitude;

Fraud or deceit in’ the acquisition of the certificate of registration,

professional identification card or temporary/special permit or renewal of
license;

18


(©) Display of certificate of registration of a pharmacist who is not actually
employed in such an establishment as required by law.

(Addiction to alcoholic beverages or to any habit-forming drug rendering him
incompetent to practice his/her profession;

(g) Aiding or abetting the illegal practice of a non-registered and licensed person
by allowing hinvher the use of his/her certificate of registration and/or
professional identification card or his/her special/temporary permit;

(b) Acting as a dummy of an alien or a person who is not qualified to establish
and operate a retail drugstore;

(i) Insanity or any mental disorder that would render the person incompetent to
practice his/her profession;

G) False, extravagant or unethical advertisements and product endorsements
where the pharmacist’s name, professional organization he/she represents,
and similar information are used;

(K) Manufacture, sale, offering for sale of counterfeit drugs and committing
other acts in violation of Sec. 4 of the Special Law on Counterfeit Drugs,
R.A. No. 8203;

(Illegal manufacturing, sale, possession, dispensing of dangerous drugs and
other pertinent acts in violation of Dangerous Drugs Act, R.A. No. 9165:

(m) Committing acts in violation of Sec. 6 of P.D. No. 881 on Hazardous
Substances; and

(n) Practicing pharmacy while under suspension.
(0) Practicing with an expired professional identification card.

Section 47. — Non-renewal of license. - The following are the grounds for the non-
renewal of professional identification card:

(@) Refusal to join or to remain a member of good standing of the AINO;
(6) Non-payment of annual registration fees for three (3) continuous years;

(c) Non-compliance with the continuing professional development requirement, for
the renewal of his/her professional identification card; and

The Board shall periodically evaluate the aforementioned grounds and revise as the
need arises subject to the approval of the Commission.

Any person, entity or organization may file charges according to the provision of
this section against any registrant, or the Board may investigate violation of any of the
abovementioned causes. Affidavit of complaint under oath shall be filed together with the
affidavits of witnesses and other documentary evidence with the Board through the Legal
and Investigation Office. The move to conduct an investigation shall be embodied in a
formal charge to be signed by at least a majority of the members of the Board. The rules on
administrative investigation issued by the Commission shall govern the hearing or

19


investigation subject to applicable provisions of this Act, R.A. No. 8981 and its rules and
regulations thereof, and Rules of Court.

Sec. 48. ~ Administrative Investigation/Sanctions, — Administrative investigations
shall be conducted by the Board assisted by the Legal or Hearing Officer of the
Commission. The existing rules of evidence shall also be observed and applied during
administrative investigations.

If the Board, by a majority vote of the members, shall find that the charges are
sustained by evidence adduced, it may, at its discretion reprimand the respondent or revoke
or suspend his certificate of registration.

See. 49. - Procedure and Rules. ~ The Board upon receipt of a formal complaint
under oath against any pharmacist shall furnish the latter a copy of the complaint, which
shall be answered in writing within ten (10) days from receipt thereof. If the Board, after
careful study of the records, finds that there is a valid ground to the charge, it shall conduct
a formal investigation and set the dates of the hearing thereof. For this purpose, a subpoena
and/or subpoena duces tecum may be issued by the chairman of the Board or by the Chief,
Legal and Investigation Division. The investigation proceedings shall at all times be
recorded. The investigation shall have been terminated and resolved within ninety (90)
days from the time the first date of hearing shall be set and heard.

See. 50. ~ Rights of Respondent. - The respondent pharmacist is entitled to be
heard or be represented by counsel: to have speedy public hearing, to confront, and to cross-
examine the witness or witnesses against him; to summon and present witness or witnesses
in his behalf; or to avail himself/herself of any other process for the protection of his/her
constitutional rights

Sec. 51. ~ Motion for Reconsideration. — A motion for reconsideration within the
prescribed period may be made based on any of the following grounds:

(a) Grave abuse of discretion by the Board,

(b) Findings not supported by substantial evidence, and Irregularity in the conduct of
investigation.

Sec. 52. — Appeal/Finality of Decision, - The decision of the Board shall
automatically become final and executory fifteen (15) days from the appropriate service of
the decision to the respondent, unless the latter within the same period, has appealed the

.decision to the Commission; provided that said decision of the Board and/or the
Commission may be appealed to the Court of Appeals.

ARTICLE VIL
PENAL PROVISIONS

Sec. 53. - Penal Provisions. - Any person who shall violate any of the provisions of
the practice of pharmacy as defined in the following provisions of Article IV:

Registration certificate (Section 32)

(@) Allowing the display of his/her registration certificate in an outlet or establishment
by a pharmacist where he/she is not employed

(b) Display of a pharmacist’s registration certificate by an outlet or establishment when
the pharmacist is not employed

20


Dispensing and compounding (Sections 27, 33, 38, 42)

(c) Dispensing done in, or offering for sale of prescription drugs in a place not licensed
by FDA as drug outlet

(d) Dispensing of prescription of and pharmacist-only over-the-counter drugs by a
person other than a registered pharmacist

(©) Dispensing of prescription drugs without presentation of a valid prescription

(© Compounding of prescription drugs and pharmacist-only over-the-counter drugs
done by a person other than a pharmacist

(g) Selling of prescription and pharmacist-only over-the-counter drugs by
manufacturers, importers, and wholesalers to unlicensed drug outlets and other drug
establishments

(h) Substitution of prescription drugs which are not generically equivalent to what was
on the prescription without the consent of the prescriber

() Compounding not in accordance with the current Good Manufacturing Practices and
Good Pharmacy Practice

(i) Forcing, coercing or intimidating a registered pharmacist to compound or dispense
drugs not in accordance with this Act

(k) Preparation and compounding of pharmaceutical products in quantities greatly in
excess of single therapeutic doses without a registered pharmacist

() Non-compliance with the labeling requirement for dispensed medicines by a drug
outlet

(m) Allowing pharmacy assistants to dispense without the supervision of a pharmacist
Requirement of Pharmacist (Sections 33,34, 36)

(n) Establishment/outlet selling prescription and pharmacist-only over-the-counter
drugs which opens for business without a licensed pharmacist

(©) Compounding by a _ non-regi
expired/revoked/suspended license

red pharmacist or pharmacist with

(p) Filling of prescription by a non-pharmacist or by a non-registered pharmacist or
pharmacist with expired/revoked/suspended license

(@) Wholesale of pharmaceutical products without the direct and immediate supervision
of a registered pharmacist

(®) Rural Health Units dispensing prescription drugs and pharmacist-only over-the-
counter drugs without the supervision of a registered pharmacist Manufacturing and
selling of pharmaceutical products under fraudulent name and address (Section 35)
Adulteration and misbranding of drugs (Section 35) Manufacturing and selling of
unsafe and substandard drugs (Section 35) shall upon conviction thereof, be
sentenced to a fine of not less than ‘Two Hundred Fifty Thousand (Php250,000.00)
Pesos but not exceeding Five Hundred Thousand (PhpS00,000.00) Pesos and/or to

21


an imprisonment of not less than one year and one day but not more than six years,
or both fine and penalty, at the discretion of the court.

See. 54. - Other Penalties. - Any person who shall violate any of the following
provisions of this A\

(a) Affixing of the title, R.Ph. by a person who is not a pharmacist and a graduate of
pharmacy degree who is not registered with PRC (Section 21)

(b) Practice of pharmacy in the Philippines by a foreigner without special permit
(Section 28)

(c) Non-indication by a pharmacist of his/her registration number and Professional Tax
Receipt number in official documents requiring such information (Section 30)

(d) Non-display of certificate of registration of a pharmacist in drug establishment
requiring such (Section 32) _

(e) Non-display of certificate of registration of a pharmacist by an establishment/outlet
(Section 32)

(0) Non-compliance with this Act’s provision on the required salary for a registered
pharmacist (Section 34)

(g) Non-compliance by a pharmacist with the requirement on the filling of prescription
(Section 36) a

(h) Non-compliance by a registered pharmacist on the requirement for partially filled
prescription (Section 36)

(i) Selling of physician’s samples (Section 37)

(@ The removal, erasure and alteration of mark or label of physician’s sample (Section
37)

(k) Non-compliance with the filling up of Record Books by a drug outlet (Section 40)

() Employment of persons in a pharmacy without the provision of the required training
(Section 42)

(m)Rendering dispensing-related services by non-pharmacists in a drug outlet without
undergoing the required training (Section 42) shall upon conviction thereof, be
sentenced to a fine of not less than One Hundred Thousand (Php100,000.00) Pesos
but not exceeding Two Hundred Thousand (Php200,000.00) Pesos or to an
imprisonment of not less than Thirty (30) days but not more than One (1) year, or
both fine and penalty at the discretion of the court.

‘Any person other than the citizens of the Philippines having been found
guilty of any violation as provided for in this and the preceding section shall, after
having paid the fine or having served his sentence or both when so adjudged, be
also subject to immediate deportation.

For any violation of the provisions of this Act penalized under this and the
preceding section, which also constitutes or considered as punishable offense or

22


described as a violation of other laws, the applicable penalty shall be that of the
law providing for a higher fine and/or imprisonment.

For any violation of the rules and regulations implementing the provisions of
this Act, appropriate penalty shall be imposed.

ARTICLE VIL
FINAL PROVISIONS

See. 55. - Enforcement. — The Commission shall be the enforcement agency of this
Act. As such, the Commission shall implement the appropriate provisions of this Act,
enforce its implementing rules and regulations as adopted by the Board, assist the Board in
the investigation of complaints against violators of this Act, its rules and regulations, Code
of Ethies for pharmacists, professional standards, and other policies of the Board and the
Commission.

The Commission and/or the Board shall call upon or request any department,
instrumentality, office, bureau, institution or agency of the government, including local
government units to render such assistance as it may require, or to coordinate or cooperate
in order to carry out, enforce or implement the provisions of this Act.

See. 56. - Appropriations. ~ The Chairperson of the PRC shall immediately include
in its programs on the implementation of this Act, the funding of which shall be charged
against their current years’ appropriations and thereafter, in the annual General
Appropriations Act.

See. 57. - Implementing Rules and Regulations. ~ Within one hundred and twenty
(120) days after the approval of this Act, the Board subject to the approval by the
Commission, in consultation with the AINO, shall issue and formulate the rules and
regulations, the Code of Ethics and professional standards for pharmacists, to effectively
implement this Act.

Sec. 88. - Separability Clause. ~ If any clause, provisions, paragraph or part

hereof shall be declared unconstitutional or invalid, such judgment shall not affect,
invalidate, impair any other part thereof, but such judgment shall be merely confined to the
+ clause, provision, paragraph or part directly involved in the controversy in which such
judgment has been rendered.

Sec. 59. - Repealing clause. ~ R.A. No. 5921, known as the Pharmacy Law, as
amended by E.0. No. 174, and PD No. 1363, and all other laws are hereby repealed,
Presidential decrees, executive orders, and other administrative issuances and parts thereof
which are inconsistent with the provisions of this Act are hereby modified, amended,
superseded or repealed accordingly.

See. 60. - Effectivity. — This Act shall take effect after fifteen (15) days following
the full and complete publication thereof in the Official Gazette or in any major daily
newspaper of general circulation in the Philippines.

Approved,

23